A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-03-30) →
What happened
Kolmar BioTech disclosed convertible bonds to raise US$24.1M, about 91.4% of its market value.
For context, this raise equals about 91.4% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$24.1M |
| vs. market value | 91.4% |
| Filed | 2026-03-03, Material event report (convertible bonds) |
| Source | DART rcept 20260303003177 → open original filing |
Versions of this filing
- 2026-03-03Original (this page)
- 2026-03-30Amendment 1
Source: DART. Information only, not investment advice.